The Viscosupplementation Market is expected to register a CAGR of 9% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The report is segmented by Course of Treatment (Single Injection and Multiple Injection), Anatomy (Knee Osteoarthritis, Hip Osteoarthritis, Ankle Osteoarthritis, and Shoulder Osteoarthritis). The report further presents analysis based on the End User (Hospitals, Clinics, and Ambulatory Surgical Centers). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Viscosupplementation Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Viscosupplementation Market Segmentation
Course of Treatment- Single Injection
- Multiple Injection
- Knee Osteoarthritis
- Hip Osteoarthritis
- Ankle Osteoarthritis
- Shoulder Osteoarthritis
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Strategic Insights
Viscosupplementation Market Growth Drivers- Growing Prevalence of Osteoarthritis: The viscosupplementation market is bound to rise in incidence of osteoarthritis, especially in the elderly. As more people need relief from arthritic pain and improve their mobility, the demand for viscosupplement injections will rise. Healthcare providers would increasingly recommend these treatments as non-invasive interventions to effectively handle the symptoms, thus propelling the growth in the market.
- Increasing Awareness of Non-Surgical Interventions: In recent years, both the patients and doctors have become increasingly conscious of the possibility of treating joint pain without calling for surgical intervention. Viscosupplementation, which is defined as the injection of hyaluronic acid-the substance restoring joint lubrication-has recently emerged and gained popularity as a relatively safer alternative procedure that hitherto was never considered as an alternative to more invasive procedures. Such a trend provokes more patients to consider viscosupplementation as a potential option for pain therapy.
- Technological Innovations in Injection Procedures: Advances in the injection technologies and the composition of viscosupplements have been major contributors toward growth of the market. The methods of delivery have become more accurate and efficient, such as ultrasound-guided injections. This enhances patient outcomes leading to higher general acceptance and use of viscosupplementation in clinical practice.
- Upward Trend Toward Personalized Medicine: The trend toward personalized medicine is also moving the viscosupplementation market forward. Since treatment varies in specificity according to the condition of the patient or the intensity of the case, it is more effective. The growing trend of the customized approach by the healthcare provider will have an increased demand for customized viscosupplement solutions, and hence, more targeted therapies against joint pain are in the way.
- Increased Use of Viscosupplementation: There is an emerging trend of increased use of viscosupplementation as adjunctive therapy with other treatments such as PT, and managing pain. This would offer better overall treatment outcomes and care for patients. As holistic care modes continue to expand in healthcare practice, it will also follow that the use of therapies with a combination of viscosupplementation will grow.
- Increased Approval for Regulatory Affairs: Approvals for new viscosupplement products by regulatory bodies is a significant trend in the market. As more and more products come into the market, competition increases, and there is even more choice for the healthcare provider or patient, but that still generates demand for more viscosupplements treatments within different healthcare settings and drives the market even more.
- Growth in emerging markets: Viscosupplementation market growth opportunities in emerging markets are tremendous. The development of health care infrastructure coupled with the provision of state-of-the-art treatment options would increase the demand for injections of viscosupplements in this sector. Companies will benefit from the same through structured distribution networks as well as customized marketing campaigns that respond to regional requirements and preferences.
- Develop New Formulations: There is now a fantastic space for new inventions of novel viscosupplement preparations with enhanced efficacy and prolonged longevity. Further research into new, undiscovered compounds or delivery systems may result in new products providing longer pain relief results. This R&D focus on next-generation viscosupplements will position companies better in the competitive market.
- Growing Interest in Sports Medicine: Growing interest in sports medicine and active lifestyles may encourage vicosupplementation. Typically, this kind of treatment for joint pain will be sought after by athletes or active people who may need their ailments to be treated or recover after an injury. Hence, directed marketing efforts to the sports professionals and fitness enthusiasts would most certainly help these companies capitalize on this growing segment.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Viscosupplementation Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Viscosupplementation Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Asia-Pacific region is likely to witness the fastest growth rate during the forecast period.
The viscosupplementation market is estimated to grow with a CAGR of 9% from 2023 to 2031.
The viscosupplementation market majorly consists of players such as Hyaluronic Acid Laboratories, Sanofi, Zimmer Biomet among others.
The growing prevalence of osteoarthritis is driving the viscosupplementation market
Approvals for new viscosupplement products is likely to remain the key trend during the forecast period.
North America dominated the viscosupplementation market in 2023
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Viscosupplementation Market - By Course of Treatment
1.3.2 Viscosupplementation Market - By Anatomy
1.3.3 Viscosupplementation Market - By End User
1.3.4 Viscosupplementation Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. VISCOSUPPLEMENTATION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. VISCOSUPPLEMENTATION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. VISCOSUPPLEMENTATION MARKET - GLOBAL MARKET ANALYSIS
6.1. VISCOSUPPLEMENTATION - GLOBAL MARKET OVERVIEW
6.2. VISCOSUPPLEMENTATION - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. VISCOSUPPLEMENTATION MARKET - REVENUE AND FORECASTS TO 2028 - COURSE OF TREATMENT
7.1. OVERVIEW
7.2. COURSE OF TREATMENT MARKET FORECASTS AND ANALYSIS
7.3. SINGLE INJECTION
7.3.1. Overview
7.3.2. Single Injection Market Forecast and Analysis
7.4. MULTIPLE INJECTION
7.4.1. Overview
7.4.2. Multiple Injection Market Forecast and Analysis
8. VISCOSUPPLEMENTATION MARKET - REVENUE AND FORECASTS TO 2028 - ANATOMY
8.1. OVERVIEW
8.2. ANATOMY MARKET FORECASTS AND ANALYSIS
8.3. KNEE OSTEOARTHRITIS
8.3.1. Overview
8.3.2. Knee Osteoarthritis Market Forecast and Analysis
8.4. HIP OSTEOARTHRITIS
8.4.1. Overview
8.4.2. Hip Osteoarthritis Market Forecast and Analysis
8.5. ANKLE OSTEOARTHRITIS
8.5.1. Overview
8.5.2. Ankle Osteoarthritis Market Forecast and Analysis
8.6. SHOULDER OSTEOARTHRITIS
8.6.1. Overview
8.6.2. Shoulder Osteoarthritis Market Forecast and Analysis
9. VISCOSUPPLEMENTATION MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. CLINICS
9.4.1. Overview
9.4.2. Clinics Market Forecast and Analysis
9.5. AMBULATORY SURGICAL CENTERS
9.5.1. Overview
9.5.2. Ambulatory Surgical Centers Market Forecast and Analysis
10. VISCOSUPPLEMENTATION MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Viscosupplementation Market Overview
10.1.2 North America Viscosupplementation Market Forecasts and Analysis
10.1.3 North America Viscosupplementation Market Forecasts and Analysis - By Course of Treatment
10.1.4 North America Viscosupplementation Market Forecasts and Analysis - By Anatomy
10.1.5 North America Viscosupplementation Market Forecasts and Analysis - By End User
10.1.6 North America Viscosupplementation Market Forecasts and Analysis - By Countries
10.1.6.1 United States Viscosupplementation Market
10.1.6.1.1 United States Viscosupplementation Market by Course of Treatment
10.1.6.1.2 United States Viscosupplementation Market by Anatomy
10.1.6.1.3 United States Viscosupplementation Market by End User
10.1.6.2 Canada Viscosupplementation Market
10.1.6.2.1 Canada Viscosupplementation Market by Course of Treatment
10.1.6.2.2 Canada Viscosupplementation Market by Anatomy
10.1.6.2.3 Canada Viscosupplementation Market by End User
10.1.6.3 Mexico Viscosupplementation Market
10.1.6.3.1 Mexico Viscosupplementation Market by Course of Treatment
10.1.6.3.2 Mexico Viscosupplementation Market by Anatomy
10.1.6.3.3 Mexico Viscosupplementation Market by End User
10.2. EUROPE
10.2.1 Europe Viscosupplementation Market Overview
10.2.2 Europe Viscosupplementation Market Forecasts and Analysis
10.2.3 Europe Viscosupplementation Market Forecasts and Analysis - By Course of Treatment
10.2.4 Europe Viscosupplementation Market Forecasts and Analysis - By Anatomy
10.2.5 Europe Viscosupplementation Market Forecasts and Analysis - By End User
10.2.6 Europe Viscosupplementation Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Viscosupplementation Market
10.2.6.1.1 Germany Viscosupplementation Market by Course of Treatment
10.2.6.1.2 Germany Viscosupplementation Market by Anatomy
10.2.6.1.3 Germany Viscosupplementation Market by End User
10.2.6.2 France Viscosupplementation Market
10.2.6.2.1 France Viscosupplementation Market by Course of Treatment
10.2.6.2.2 France Viscosupplementation Market by Anatomy
10.2.6.2.3 France Viscosupplementation Market by End User
10.2.6.3 Italy Viscosupplementation Market
10.2.6.3.1 Italy Viscosupplementation Market by Course of Treatment
10.2.6.3.2 Italy Viscosupplementation Market by Anatomy
10.2.6.3.3 Italy Viscosupplementation Market by End User
10.2.6.4 Spain Viscosupplementation Market
10.2.6.4.1 Spain Viscosupplementation Market by Course of Treatment
10.2.6.4.2 Spain Viscosupplementation Market by Anatomy
10.2.6.4.3 Spain Viscosupplementation Market by End User
10.2.6.5 United Kingdom Viscosupplementation Market
10.2.6.5.1 United Kingdom Viscosupplementation Market by Course of Treatment
10.2.6.5.2 United Kingdom Viscosupplementation Market by Anatomy
10.2.6.5.3 United Kingdom Viscosupplementation Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Viscosupplementation Market Overview
10.3.2 Asia-Pacific Viscosupplementation Market Forecasts and Analysis
10.3.3 Asia-Pacific Viscosupplementation Market Forecasts and Analysis - By Course of Treatment
10.3.4 Asia-Pacific Viscosupplementation Market Forecasts and Analysis - By Anatomy
10.3.5 Asia-Pacific Viscosupplementation Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Viscosupplementation Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Viscosupplementation Market
10.3.6.1.1 Australia Viscosupplementation Market by Course of Treatment
10.3.6.1.2 Australia Viscosupplementation Market by Anatomy
10.3.6.1.3 Australia Viscosupplementation Market by End User
10.3.6.2 China Viscosupplementation Market
10.3.6.2.1 China Viscosupplementation Market by Course of Treatment
10.3.6.2.2 China Viscosupplementation Market by Anatomy
10.3.6.2.3 China Viscosupplementation Market by End User
10.3.6.3 India Viscosupplementation Market
10.3.6.3.1 India Viscosupplementation Market by Course of Treatment
10.3.6.3.2 India Viscosupplementation Market by Anatomy
10.3.6.3.3 India Viscosupplementation Market by End User
10.3.6.4 Japan Viscosupplementation Market
10.3.6.4.1 Japan Viscosupplementation Market by Course of Treatment
10.3.6.4.2 Japan Viscosupplementation Market by Anatomy
10.3.6.4.3 Japan Viscosupplementation Market by End User
10.3.6.5 South Korea Viscosupplementation Market
10.3.6.5.1 South Korea Viscosupplementation Market by Course of Treatment
10.3.6.5.2 South Korea Viscosupplementation Market by Anatomy
10.3.6.5.3 South Korea Viscosupplementation Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Viscosupplementation Market Overview
10.4.2 Middle East and Africa Viscosupplementation Market Forecasts and Analysis
10.4.3 Middle East and Africa Viscosupplementation Market Forecasts and Analysis - By Course of Treatment
10.4.4 Middle East and Africa Viscosupplementation Market Forecasts and Analysis - By Anatomy
10.4.5 Middle East and Africa Viscosupplementation Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Viscosupplementation Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Viscosupplementation Market
10.4.6.1.1 South Africa Viscosupplementation Market by Course of Treatment
10.4.6.1.2 South Africa Viscosupplementation Market by Anatomy
10.4.6.1.3 South Africa Viscosupplementation Market by End User
10.4.6.2 Saudi Arabia Viscosupplementation Market
10.4.6.2.1 Saudi Arabia Viscosupplementation Market by Course of Treatment
10.4.6.2.2 Saudi Arabia Viscosupplementation Market by Anatomy
10.4.6.2.3 Saudi Arabia Viscosupplementation Market by End User
10.4.6.3 U.A.E Viscosupplementation Market
10.4.6.3.1 U.A.E Viscosupplementation Market by Course of Treatment
10.4.6.3.2 U.A.E Viscosupplementation Market by Anatomy
10.4.6.3.3 U.A.E Viscosupplementation Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Viscosupplementation Market Overview
10.5.2 South and Central America Viscosupplementation Market Forecasts and Analysis
10.5.3 South and Central America Viscosupplementation Market Forecasts and Analysis - By Course of Treatment
10.5.4 South and Central America Viscosupplementation Market Forecasts and Analysis - By Anatomy
10.5.5 South and Central America Viscosupplementation Market Forecasts and Analysis - By End User
10.5.6 South and Central America Viscosupplementation Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Viscosupplementation Market
10.5.6.1.1 Brazil Viscosupplementation Market by Course of Treatment
10.5.6.1.2 Brazil Viscosupplementation Market by Anatomy
10.5.6.1.3 Brazil Viscosupplementation Market by End User
10.5.6.2 Argentina Viscosupplementation Market
10.5.6.2.1 Argentina Viscosupplementation Market by Course of Treatment
10.5.6.2.2 Argentina Viscosupplementation Market by Anatomy
10.5.6.2.3 Argentina Viscosupplementation Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. VISCOSUPPLEMENTATION MARKET, KEY COMPANY PROFILES
12.1. BIOVENTUS INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ANIKA THERAPEUTICS
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. SEIKAGAKU CORPORATION
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ZIMMER BIOMET
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. SMITH AND NEPHEW PLC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. FERRING B.V.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. LIFECORE BIOMEDICAL, LLC (LANDEC)
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SALIX PHARMACEUTICALS
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. FIDIA FARMACEUTICI S.P.A
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. LG LIFE SCIENCES LTD.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Bioventus Inc.2. Anika Therapeutics3. Seikagaku Corporation4. Zimmer Biomet5. Smith & Nephew PLC6. Ferring B.V.7. Lifecore Biomedical, LLC (Landec)8. Salix Pharmaceuticals9. Fidia Farmaceutici S.P.A10. LG Life Sciences Ltd.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For